Can PTSD deteriorate women’s cardiovascular and neurological health?

Whether posttraumatic stress disorder (PTSD) symptoms in civilian midlife women negatively affected their cardiovascular and neurocognitive health.

No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says

By way of two resoundingly consistent votes, members of an FDA advisory committee agreed that PD-1 inhibitors do not have a favorable risk/benefit profile for

September 28, 2024

Nagi Bioscience launches exclusive Priority Access Program, bringing revolutionary SydLab™ One platform to five leading academic labs for C. elegans research

Nagi Bioscience, a pioneer Swiss company pioneer in cutting-edge laboratory technologies for alternative model organisms research, proudly announces the launch of its exclusive Priority Access

September 20, 2024

Brazilian researchers create cutting-edge nanoparticle weapon against tuberculosis

A low-cost technology involving nanoparticles loaded with antibiotics and other antimicrobial compounds that can be used in multiple attacks on infections by the bacterium responsible

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.